Master in Vaccinology and Drug Development

15/04/2026

Despite significant advances in vaccination, access remains uneven across regions.
While some populations benefit from high immunization coverage, others continue to face shortages, logistical barriers, and limited healthcare infrastructure — increasing the risk of preventable disease outbreaks 💉

Addressing these disparities is essential to achieving equitable and effective global health systems.

🌐ifgh.org

10/04/2026

Access to vaccines shouldn’t be a privilege 🌍

Equitable access to vaccines is a fundamental component of public health.
Ensuring widespread immunization not only protects individuals, but also strengthens communities, reduces the risk of outbreaks, and supports the resilience of health systems worldwide 💉

Addressing disparities in access remains essential to achieving global health equity.

ifgh.org

07/04/2026

April 7 – World Health Day 🌍

World Health Day highlights the importance of strengthening health systems and advancing equitable access to healthcare worldwide.

Prevention remains at the core of global health strategies, with vaccination playing a fundamental role in reducing disease burden and protecting populations 💉

Continued collaboration across scientific, medical, and public health communities is essential to address current challenges and build more resilient health systems 🧪

ifgh.org

01/04/2026

Vaccines are among the most rigorously tested medical products in the world. 🧪

Before approval, they undergo multiple phases of clinical trials involving thousands of volunteers—and even after introduction, their safety continues to be monitored globally by independent experts and health authorities. 🌍

Over the past 50 years, vaccines against just 14 diseases have helped save at least 154 million lives worldwide. 💉

Understanding how vaccine safety is evaluated is essential for building trust in immunization and strengthening public health systems. 🤝

Learn more from WHO’s vaccine safety Q&A:
https://www.who.int/news-room/questions-and-answers/item/vaccines-and-immunization-vaccine-safety

ifgh.org

27/03/2026

🎓 Our graduates return home with more than a Master’s degree—they return ready to create impact.

Through the Master in Vaccinology and Drug Development, they gain a deeper understanding of epidemiology and public health priorities in their own countries, together with strong, practical expertise in vaccinology and immunization.

Guided by leading international experts, they go back prepared to contribute knowledge, leadership, and solutions where they are needed most. 🌍💉

🌐 www.ifgh.org

25/03/2026

📲 Be part of our global community and stay up to date with the latest in vaccinology and drug development!

Follow us and connect with experts, students, and professionals around the world:
🔹 Instagram: https://www.instagram.com/master.in.vaccinology

🔹 LinkedIn: https://www.linkedin.com/company/master-in-vaccinology-and-drug-development

🔹 X (Twitter): https://x.com/InVaccinology

🔹 Facebook: https://www.facebook.com/vaccinology.drug.development

🌐 Learn more at www.ifgh.org

20/03/2026

The global threat of vaccine-preventable neurological diseases 🧠💉

Vaccination is one of the greatest achievements in public health, yet declining immunization coverage is allowing the resurgence of diseases that can severely affect the nervous system.

A recent review highlights that infections such as measles, poliomyelitis, Japanese encephalitis, meningococcal disease, and pertussis can lead to serious neurological complications, including acute and chronic disability and high mortality.

Factors contributing to this resurgence include:
🔹 Vaccine hesitancy and misinformation
🔹 Disruptions in immunization programs
🔹 Limited access to vaccines in some regions
🔹 Geopolitical instability and strained health systems

Strengthening global vaccination strategies, equitable access to vaccines, and public health education will be essential to prevent a growing burden of vaccine-preventable neurological diseases and protect vulnerable populations.

Read the full article:
https://www.nature.com/articles/s41582-025-01172-w

18/03/2026

How are vaccines developed and approved? 🧪💉

Developing a vaccine is a rigorous scientific process that can take years and involves multiple stages designed to ensure safety, quality, and effectiveness.

According to the CDC, the process typically includes:
🔬 Research and discovery
🧫 Pre-clinical studies
👥 Clinical trials (Phases 1–3)
🏭 Manufacturing and quality control
📑 Regulatory review and approval
📊 Continuous safety monitoring after approval

Even after a vaccine is licensed, surveillance systems continue monitoring safety and effectiveness in real-world populations.

Understanding this process helps build trust in vaccines and highlights the scientific rigor behind their development.

🌐ifgh.org

12/03/2026

Aluminum Exposure and Health: What the Evidence Shows 🔬🧠

Aluminum is one of the most abundant elements in the environment, and human exposure occurs daily through food, water, medications, and some medical products. A recent article published in JAMA provides an updated overview of sources of aluminum exposure, biological handling, and current evidence on potential health effects.

Key points highlighted include:

🔹 Aluminum absorption is generally low and tightly regulated in healthy individuals
🔹 The kidneys play a central role in aluminum elimination
🔹 Adverse health effects are primarily associated with high or prolonged exposure, particularly in patients with impaired renal function
🔹 Ongoing research continues to refine safe exposure thresholds using modern toxicological and epidemiological methods

For vaccinology and drug development professionals, this topic is especially relevant as it reinforces the importance of:

✔️ Evidence-based risk assessment
✔️ Distinguishing exposure from toxicity
✔️ Communicating safety data clearly to counter misinformation
✔️ Relying on high-quality clinical and population-level evidence

Understanding aluminum exposure requires context, dose, and biology — not assumptions.

🔗 Read more:
https://jamanetwork.com/journals/jama/fullarticle/2844763

This Perspective examines aluminum exposure from vaccines and diet, including how the body processes aluminum, possible health effects, and safety considerations.

06/03/2026

The Master in Vaccinology and Drug Development shapes professionals who drive progress in vaccine research, policy, and implementation across the world.

For more than a decade, our graduates have taken leadership roles in organizations that transform scientific discovery into life-saving solutions. 💉🎓

🌐 ifgh.org

04/03/2026

Polio: A Reminder of Why Vaccines Matter 💉🦠

Approximately 1 in 200 poliovirus infections leads to irreversible paralysis — a devastating outcome that once shaped entire generations.

In the 1950s and 1960s, children with paralytic polio often depended on iron lungs to survive, as the virus impaired the muscles required for breathing 🫁⚙️. These machines became a symbol of the burden polio placed on families and health systems worldwide.

Today, we rarely see iron lungs — not because polio disappeared on its own, but because vaccination changed the course of history 📉🌍.

For vaccinology and public health professionals, polio remains a powerful case study:
✔️ The life-saving impact of effective vaccines
✔️ The importance of sustained immunization coverage
✔️ The risk of resurgence when vaccination gaps emerge

Polio reminds us that the absence of disease is often the success of prevention — not its irrelevance.

ifgh.org

02/03/2026

Reverse Vaccinology and Next-Generation Vaccine Discovery 🔍🧬💡

A recent ScienceDirect article discusses one of the most promising innovations in modern vaccine science: reverse vaccinology — a genomics-driven approach that uses bioinformatics to identify potential vaccine antigens directly from pathogen genomes. Unlike traditional methods that rely on culturing microbes, reverse vaccinology accelerates discovery by scanning entire proteomes to pinpoint targets for protective immune responses.

This strategy has already revolutionized vaccine research for several pathogens and illustrates how computational tools and systems biology are reshaping antigen discovery and design. By combining genomic data with predictive algorithms, researchers can rapidly shortlist candidates that could lead to effective vaccines — especially important for pathogens where classic approaches have struggled.

Key takeaways for vaccinology professionals:
• 🧠 Genomics accelerates candidate antigen discovery
• 📊 Bioinformatics bridges genome data with immunogenic prediction
• 🧪 Targets identified in silico can inform novel vaccine design faster
• 🔄 This approach complements structural and systems vaccinology to enable next-generation vaccines for complex or emerging diseases.
👇
Read the full article to explore how reverse vaccinology is influencing the future of vaccine development:
👉 https://www.sciencedirect.com/science/article/abs/pii/S0264410X25014859